Biotech

All Articles

Roche throws out $120M tau possibility, giving back civil rights to UCB

.Roche has come back the civil liberties to UCB's anti-tau antitoxin bepranemab, ignoring a $120 mil...

Editas builds up in vivo tactic using $238M Genenvant deal

.Editas Medicines has actually signed a $238 million biobucks deal to blend Genevant Scientific rese...

Combo end results, Vicodin skip and also stellar protection

.Vertex has stated phase 3 information on its near-approval ache drug prospect suzetrigine, clarifyi...

Angelini pens $360M biobucks pact for ph. 1 brain disorder drug

.Italy's Angelini Pharma has signed a $360 thousand biobucks pact centered on a period 1-stage mind ...

Sage lays off fifty percent of R&ampD staff and shocks C-suite again

.Sage Rehabs' most recent effort to diminish its pipe and labor force will view a third of the biote...

With period 1 information, Atmosphere has an eye on early-stage bladder cancer cells

.With its own lead candidate in a phase 3 trial for a rare eye cancer cells, Feeling Biosciences is ...

Less than a year in, BenevolentAI chief executive officer is actually out-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also ...

Roche MAGE-A4 test withdrawn after key customer review

.Roche has actually created one more MAGE-A4 course vanish, taking out a period 1 test of a T-cell b...

FDA puts partial hang on BioNTech-OncoC4 phase 3 trial

.The FDA has applied a predisposed hang on a stage 3 non-small tissue lung cancer practice run by Bi...

REGiMMUNE, Kiji merge to generate Treg 'extremely firm,' strategy IPO

.Taiwan's REGiMMUNE and also Europe-based Kiji Therapeutics are actually combining to produce a glob...